About
Dr Sean Hall, MD, PhD, MBA
A globally experienced healthcare executive, clinician, author and strategic advisor working at the intersection of science, regulation, governance and global markets.
Professional bio
Dr Sean Hall, MD, PhD, MBA, is recognised for his ability to operate at the intersection of science, regulation, governance and global markets, supporting organisations and institutions through complex, high-stakes decisions.
He has served as Chairman, Chief Executive Officer and Managing Director across public and private healthcare enterprises operating in the United States, Europe, the United Kingdom and Australia. His leadership spans early-stage discovery, advanced clinical development, global regulatory engagement, commercial scale-up and public-market readiness, and brings a pragmatic, execution-focused perspective shaped by direct responsibility for outcomes in regulated, capital-intensive environments.
As an innovator, Dr Hall is the inventor and patent holder of internationally protected platforms in advanced therapeutic delivery and microbiome science. He has led the translation of proprietary technologies from research through clinical validation to global commercial application, balancing innovation with regulatory discipline and patient safety.
Dr Hall is a published researcher with peer-reviewed contributions across clinical medicine, microbiome science, immunology, cannabinoid therapeutics and healthcare innovation. In 2024 he authored Dysevolution: We May Never Be the Same Again, examining the systemic drivers of chronic illness and their implications for future healthcare systems.
Alongside his executive and research roles, Dr Hall provides independent strategic advisory services to boards, governments and senior leadership teams. Engagements are characterised by discretion, intellectual rigour and a clear bias toward implementable outcomes aligned with public interest and long-term enterprise value.
His clinical practice is research-based: he does not see patients outside approved clinical trial settings.
Executive profile
Experience that shapes the advice
Chairman & CEO leadership
Chairman, Chief Executive Officer and Managing Director across public and private healthcare and life sciences enterprises, leading organisations through clinical development, global commercialisation and enterprise transformation, from early-stage innovation to public-market readiness.
Board-level governance & capital strategy
Experienced in board governance, executive accountability, investor engagement and capital strategy. Advises boards on governance frameworks, risk management, growth strategy and long-term value creation.
FDA, EMA and TGA regulatory experience
Has led clinical and regulatory strategy across the United States, Europe and Australia, guiding therapeutic programs through regulatory engagement, evidence development and compliance pathways.
Inventor & international patent holder
Inventor on 47 patents globally, including advanced drug delivery and microbiome-based platforms, translated into protected IP with real-world clinical and commercial application.
Published researcher & author
35+ peer-reviewed papers covering the human microbiome, delivery systems, pain, mental health and health policy. Author of Dysevolution: We May Never Be the Same Again (2024).
Martial artist & charity supporter
30+ years training across Taekwondo, Kendo, Iaido and Brazilian Jiu-Jitsu. Supports children's charities including Chelsea's Hope Lafora Children Research Fund.
Work with Dr Hall
Board advisory, government briefings, keynotes and media commentary.